alexa Influenza pandemic planning and performance in Canada, 2009.
Immunology

Immunology

Journal of Vaccines & Vaccination

Author(s): Kendal AP, MacDonald NE

Abstract Share this page

Abstract This commentary evaluates Canadian actions following identification of pH1N1 influenza virus in 2009. We also report on some international issues affecting vaccine manufacture, and compare pH1N1 influenza vaccination programs in several industrialized countries. WHO's pandemic declaration was the trigger for Canada to take the following steps: (1) implement its sole source pandemic vaccine supply contract, (2) use an alternate, internationally-developed approach to authorize emergency use of adjuvant-containing vaccine not yet fully approved in Canada, (3) release stocks of antiviral, and (4) develop many health-related policies, through committees other than those normally used outside a pandemic. We note key successes and challenges in these steps, and suggest responses to two priority issues: first, improve planning for surges in demand for the clinical services that represent the main way in which severe disease impact was reduced, and second, establish from the outset of Public Health planning that immunization programs will phase use of vaccine in different target groups, as done elsewhere, reflecting realistic vaccine delivery rates and the likely early occurrence of the main epidemic wave.
This article was published in Can J Public Health and referenced in Journal of Vaccines & Vaccination

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords